Treatment of Narcolepsy with Modafinil

Introduction to Modafinil Therapy

The American Academy of Sleep Medicine recommends modafinil as the first-line treatment for excessive daytime sleepiness in narcolepsy due to its strong efficacy and better safety profile compared to amphetamine-based medications like Adderall 1

Modafinil is strongly recommended for treating excessive daytime sleepiness in adults with narcolepsy, showing clinically significant improvements in daytime sleepiness, disease severity, and quality of life 1
Typical dosing is 200-400 mg daily, taken in the morning or divided between morning and midday 2
Modafinil is a Schedule IV controlled substance with lower abuse potential compared to amphetamines 1, 2
Common side effects include insomnia, nausea, diarrhea, headache, and dry mouth 1, 2
Serious but rare side effects include Stevens-Johnson syndrome, particularly in pediatric patients 2
Modafinil may cause fetal harm based on animal data, with a report showing higher rates of congenital anomalies in children exposed in utero 1, 2
Modafinil may reduce the effectiveness of oral contraceptives 1

First-line therapy: Modafinil 200 mg daily in the morning, with potential increase to 400 mg daily, monitoring for common side effects including headache, insomnia, and nausea 1, 2
Not recommended during pregnancy due to potential fetal harm 1, 2
Regular follow-up is essential when starting or adjusting doses of modafinil, with monitoring for adverse effects including hypertension, palpitations, and arrhythmias 2